{
    "organizations": [],
    "uuid": "936b602fff7e911f16bd1a410b094887861a600e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-intec-pharma-announces-proposed-pu/brief-intec-pharma-announces-proposed-public-offering-of-ordinary-shares-idUSASC09VGF",
    "ord_in_thread": 0,
    "title": "BRIEF-Intec Pharma Announces Proposed Public Offering Of Ordinary Shares",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10 (Reuters) - Intec Pharma Ltd:\n* INTEC PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF ORDINARY SHARES\n* INTENDS TO USE NET PROCEEDS FROM OFFERING TO FUND ITS PHASE III CLINICAL TRIAL FOR ACCORDION PILL CARBIDOPA/LEVODOPA, OTHERS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-11T04:09:00.000+03:00",
    "crawled": "2018-04-11T18:01:27.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "intec",
        "pharma",
        "ltd",
        "intec",
        "pharma",
        "announces",
        "proposed",
        "public",
        "offering",
        "ordinary",
        "share",
        "intends",
        "use",
        "net",
        "proceeds",
        "offering",
        "fund",
        "phase",
        "iii",
        "clinical",
        "trial",
        "accordion",
        "pill",
        "others",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}